Figure 2.
Kaplan-Meier curves for cardiovascular events in patients with or without ARNI.
Kaplan-Meier curves were shown for the cumulative rate of cardiovascular events during the follow-up period in patients in both groups. (A) The cumulative rate of cardiovascular events during the follow-up period in patients in control group compared with the patients in ARNI group; (B) the cumulative incidence of cardiovascular events during the follow-up period in patients in the RASi-treated subgroup of the control group compared with the patients in ARNI group. Abbreviations: ARNI, angiotensin receptor-neprilysin inhibitor; RASi, renin-angiotensin system inhibitors; 95% CI, 95% confidence interval; HR, hazard ratio. p < 0.05 was considered to be statistically significant.